Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,080 | 3,633 | 4,307 | 4,622 | 4,060 |
| Receivables | 1,878 | 1,518 | 1,496 | 1,443 | 1,576 |
| Inventories | 2,803 | 2,779 | 2,470 | 2,268 | 2,126 |
| TOTAL | $7,926 | $8,130 | $8,405 | $8,506 | $7,914 |
| Non-Current Assets | |||||
| PPE Net | 186 | 142 | 152 | 88 | 98 |
| Intangibles | 1,367 | 1,389 | 1,411 | 1,452 | 1,496 |
| Other Non-Current Assets | 1,621 | 1,755 | 1,893 | 873 | 878 |
| TOTAL | $3,174 | $3,286 | $3,456 | $2,413 | $2,472 |
| Total Assets | $11,100 | $11,416 | $11,861 | $10,919 | $10,386 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,159 | 1,114 | 873 | 805 | 302 |
| Accrued Expenses | 435 | 413 | 794 | 712 | 572 |
| TOTAL | $1,952 | $1,929 | $2,113 | $1,828 | $1,197 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,222 | 1,307 | 1,390 | 469 | 534 |
| TOTAL | $1,222 | $1,307 | $1,390 | $469 | $534 |
| Total Liabilities | $3,174 | $3,236 | $3,503 | $2,297 | $1,731 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,544 | 10,544 | 10,544 | 10,485 | 10,485 |
| Common Shares | 11 | 10 | 10 | 10 | 10 |
| Retained earnings | -144,864 | -144,575 | -144,406 | -143,752 | -143,570 |
| TOTAL | $7,926 | $8,180 | $8,358 | $8,622 | $8,655 |
| Total Liabilities And Equity | $11,100 | $11,416 | $11,861 | $10,919 | $10,386 |